Keywords: fujisawa, buys, stake, pharmingen, japan, pharmaceutical, made
Fujisawa Buys 18.6% Stake In PharMingen
Article | 08 April 1996
Japan's Fujisawa Pharmaceutical has made a $10 million equity investment in US biotechnology company PharMingen, giving it an 18.6% stake in the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
